Lantern Pharma, Inc. (LTRN)
3.00
-0.14
(-4.46%)
USD |
NASDAQ |
May 18, 16:00
2.94
-0.06
(-2.00%)
After-Hours: 20:00
Lantern Pharma Cash and Short Term Investments (Quarterly) : 6.323M for March 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| BioVie, Inc. | 13.10M |
| Vertex Pharmaceuticals, Inc. | 7.259B |
| Spero Therapeutics, Inc. | 56.13M |
| Replimune Group, Inc. | 269.14M |
| Acurx Pharmaceuticals, Inc. | 9.255M |